Friday, July 10, 2026

pharma · Duchenne muscular dystrophy (DMD) · JAK2V617F-positive high-risk Polycythemia Vera

ITALFARMACO S.P.A

ITALFARMACO S.P.A trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Cinisello Balsamo, IT HQ
1938 Founded
629 Employees
EMA registrant Type
Company details
Status
Public
HQ
Cinisello Balsamo, IT
Founded
1938
Employees
629
Programs
7
Drugs
17
Patents
0
Intelligence · Clinical Trials

ITALFARMACO S.P.A clinical trials

Registry index of 7 ClinicalTrials.gov studies linked to ITALFARMACO S.P.A programs — each row shows trial ID, program name, phase, status, and indication.

ITALFARMACO S.P.A trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

7 updates

Latest clinical program signals indexed for ITALFARMACO S.P.A.

  1. DSC/14/2357/50 — Phase 3

    Clinical update
  2. DSC/08/2357/32 — Phase 3

    Clinical update
  3. ITF2357-60 — Phase 1

    Clinical update
  4. EFFI2021/01 — Approved

    Clinical update
  5. DSC/11/2357/44 — Phase 2

    Clinical update
  6. ITF2357 — Phase 2

    Clinical update
  7. ITF2357 — Phase 3

    Clinical update

Trial registry

7 studies